STAR SPORTS MED (01609) announced its interim results, with a net profit of 27.402 million yuan, a year-on-year decrease of 26.1%.

STAR SPORTS MED (01609) announced its mid-term results for 2026, with revenue of approximately 163 million yuan, a year-on-year increase of 21.6%; net profit of 27.402 million yuan, a year-on-year decrease of 26.1%; adjusted profit of 48.897 million yuan, a year-on-year increase of 24.3%; and basic earnings per share of 0.57 yuan. The announcement stated that the revenue growth was primarily due to the company's accelerated international market expansion strategy, which significantly increased its coverage and business scale in overseas markets. During the period, sales revenue from overseas amounted to approximately 40.698 million yuan, representing a year-on-year increase of 70.6% compared to the same period in 2025. Overseas revenue accounted for 24.9% of total revenue.